Isotope

EQS-News: Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG

Retrieved on: 
Thursday, October 26, 2023
Federal Executive Boards, Radionuclide, Radiopharmaceutical, PTX, Core, ISIN, Bank statement, Supervisory board, SDAX, Risk, Isotope, Share repurchase, Cancer, Property management, Management

Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG

Key Points: 
  • Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG
    The issuer is solely responsible for the content of this announcement.
  • The Executive Board of Eckert & Ziegler AG (ISIN DE0005659700, SDAX) resolved at its meeting today, with the approval of the Supervisory Board, the strategy and investment priorities for the coming years.
  • In this context the Supervisory Board of Eckert & Ziegler AG  has given its approval to the Executive Board to examine and prepare a split-off of up to 100 percent of the shares in the Pentixapharm AG (PTX).
  • Here we are the market leader and want to remain so," explained Dr. Harald Hasselmann, Chairman of the Executive Board of Eckert & Ziegler AG.

Professor Mike Gorley From UK Atomic Energy Authority to Join Board of Directors of ASP Isotopes Inc.

Retrieved on: 
Thursday, October 19, 2023
HALEU, Laboratory, Engineering, ODS, University of Oxford, Science, University of Bristol, EUROfusion, UK Atomic Energy Authority Constabulary, Isotope, Doctor of Philosophy, University, Materials science, ASPI, Lithium

Professor Gorley is Chief Technologist at the UK Atomic Energy Authority and a visiting Professor at the University of Bristol, U.K.

Key Points: 
  • Professor Gorley is Chief Technologist at the UK Atomic Energy Authority and a visiting Professor at the University of Bristol, U.K.
  • For the past three years, Mike has served as a Strategic leader and program area manager for fusion technology at the UK Atomic Energy Authority.
  • Paul Mann, Chairman and CEO of ASP Isotopes Inc. said, “We are pleased to welcome Professor Gorley to the Board of Directors of ASP Isotopes.
  • Following these changes to the board of directors, the Company expects to comply with NASDAQ listing requirements regarding the number and ratio of independent and non-independent directors.

Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient Treated with the New ZAP-X® Gyroscopic Radiosurgery® Platform

Retrieved on: 
Tuesday, October 24, 2023
Radiology, Surgery, Oncology, Health, Medical Devices, Hospitals, Health Technology, Other Health, Radiosurgery, Brain, Patient, Isotope, Radiation, SRS, Multimedia, Medical device, Medical imaging

ZAP Surgical, a leading innovator in the field of surgical robotics, today announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan.

Key Points: 
  • ZAP Surgical, a leading innovator in the field of surgical robotics, today announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan.
  • The event took place on October 19th, marking a significant milestone in the field of neurosurgical care and cancer treatment.
  • Kamiyacho Neurosurgical Clinic, located on the 2nd floor of the Tokyo World Gate Tower, is the second healthcare facility in Japan to introduce the ZAP-X platform.
  • View the full release here: https://www.businesswire.com/news/home/20231019369649/en/
    The front reception at Kamiyacho Neurosurgical Clinic, showcasing the ZAP-X platform with floor to ceiling windows.

General Fusion and Kyoto Fusioneering Sign MOU to Accelerate Commercialization of Magnetized Target Fusion

Retrieved on: 
Wednesday, October 11, 2023
MOU, Kyoto University, Engineering, Plasma, Tritium, Seawater, Organization, MTF, Isotope, General Fusion, Deuterium, Laser, Magnetized target fusion, Hydrogen, Face, Lithium, 3D printing

RICHMOND, British Columbia and TOKYO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion and Kyoto Fusioneering announced a Memorandum of Understanding (MOU) to accelerate the commercialization of General Fusion’s proprietary Magnetized Target Fusion (MTF) technology, aiming for grid integration in the early to mid-2030s.

Key Points: 
  • RICHMOND, British Columbia and TOKYO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion and Kyoto Fusioneering announced a Memorandum of Understanding (MOU) to accelerate the commercialization of General Fusion’s proprietary Magnetized Target Fusion (MTF) technology, aiming for grid integration in the early to mid-2030s.
  • Tritium, a hydrogen isotope and key fusion fuel, does not occur naturally and must be produced or “bred” in the fusion process.
  • Kyoto Fusioneering specializes in fusion power plant systems that complement the plasma confinement core, are applicable to various fusion confinement concepts, such as MTF, and are on the critical path for fusion commercialization.
  • “Harnessing the unique technological and engineering expertise of Kyoto Fusioneering will be instrumental as we translate LM26’s groundbreaking results into the world’s first Magnetized Target Fusion power plant.”
    "We're thrilled to join forces with General Fusion.

ASP Isotopes Announces Private Placement of Approximately $8 Million Shares of Common Stock, Priced “At the Market” Under NASDAQ Rules

Retrieved on: 
Monday, October 9, 2023
Uranium, Isotope, PIPE, ROI, ASPI, HALEU, Security (finance), Sale, Cryptocurrency, Property management, Via

The oversubscribed private placement was priced “At the Market.” The gross proceeds to the Company from the private placement are expected to be approximately $8 million before deducting the offering expenses payable by the Company.

Key Points: 
  • The oversubscribed private placement was priced “At the Market.” The gross proceeds to the Company from the private placement are expected to be approximately $8 million before deducting the offering expenses payable by the Company.
  • The closing of the private placement is subject to the satisfaction of customary closing conditions.
  • Ocean Wall Limited is acting as the sole placement agent for the private placement.
  • Paul Mann, Chairman and CEO of ASP Isotopes Inc., said, “We are delighted to welcome the Tees River Fund as a strategic institutional shareholder in this placement.

LIS Technologies Inc. Recognized as Official Member of the Department of Energy (DOE) High-Assay Low-Enriched Uranium (HALEU) Consortium

Retrieved on: 
Wednesday, October 4, 2023
United States Department of Energy, Partnership, TerraPower, Small modular reactor, Uranium, Research, Environmental policy of the Joe Biden administration, Sodium, Government, HALEU, Inflation, Rolls-Royce SMR, Acquisition, LIS, Knowledge, Inflation Reduction Act of 2022, Isotope, Uranium mining, Renewable energy

Members of the HALEU consortium are expected to play a significant role in the deployment and commercialization of advanced nuclear reactors and related infrastructure in the United States.

Key Points: 
  • Members of the HALEU consortium are expected to play a significant role in the deployment and commercialization of advanced nuclear reactors and related infrastructure in the United States.
  • As part of the Inflation Reduction Act, $700 million has been earmarked to support the development of a domestic supply chain for HALEU.
  • The money must be applied by 2026, underscoring how important domestic uranium enrichment capabilities are to the Biden Administration.
  • Establishing a secure supply of this crucial fuel, both in the short and long term, at a national level, signifies a significant stride towards bolstering energy accessibility and sovereignty.”

ASP Isotopes Issues Letter to Shareholders

Retrieved on: 
Tuesday, October 3, 2023
Semiconductor, NEI, Uranium, Electronics, Nuclear Energy Institute, Electricity, LEU, Isotope, DOE, Lithium, HALEU, Plant, Coal, Rolls-Royce SMR, Laser, ASPI, United Kingdom, SMR, Letter, Nuclear energy, Void coefficient, Safety, Carbon-14, United States Department of Energy, Rare-earth element, Renewable energy, Uranium mining, Insurance

WASHINGTON, Oct. 03, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann.

Key Points: 
  • WASHINGTON, Oct. 03, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann.
  • The company plans to use that cash flow to start the construction of additional plants in 2024 for other isotopes.
  • The United States Department of Energy (DOE) and every other Western government identifies isotopes as a critical material.
  • We hope to sign more supply agreements for essential isotopes in the coming months.

China University of Geosciences (Beijing) Researchers Provide New Insights into the Formation of the Tibetan Plateau

Retrieved on: 
Thursday, September 28, 2023
Nature Geoscience, Oxygen, Biodiversity, Weather, Altitude, Earth science, Isotope, Nature, History, School, Tea, Granite

The Tibetan Plateau is usually thought to have been formed by the collision between the Indian and Eurasian plates.

Key Points: 
  • The Tibetan Plateau is usually thought to have been formed by the collision between the Indian and Eurasian plates.
  • But this claim is controversial owing to a lack of unaltered terrestrial sediments required for estimating the past elevation of the Tibetan Plateau through paleoaltimetry techniques.
  • Now, a groundbreaking study, led by Professor Chengshan Wang from the School of Earth Sciences and Resources at China University of Geosciences, has employed an innovative approach to paleoaltimetry to obtain remarkable insights into the formation of the Tibetan Plateau.
  • The Tibetan Plateau has always fascinated humankind, but this study brings us a step closer to the understanding of its remarkable history.

ASP Isotopes Inc. Enters Into Memorandum of Understanding With a Small Modular Reactor Company To Supply High Assay Low Enriched Uranium (HALEU)

Retrieved on: 
Thursday, September 28, 2023
Oxygen, Small modular reactor, Nuclear Energy Institute, Electricity, Isotope, HALEU, Silicon, Nuclear energy, Rolls-Royce SMR, Investment, Nuclear fusion, ASPI, MOU, United Kingdom, SMR, Memorandum, Void coefficient, Lithium, Tourism, Uranium mining, Renewable energy

WASHINGTON, Sept. 28, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (“ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today announced that it has entered into a memorandum of understanding (MOU) with a major SMR (small modular reactor) company and is also engaged in discussions with at least four other potential customers regarding the development of a High Assay Low Enriched Uranium (HALEU) production facility with financial support from these future potential customers.

Key Points: 
  • These discussions include providing financial support for the development of a production facility and the future supply of metric tons of HALEU.
  • The Company is in discussions with potential customers who anticipate requiring over $30 billion(1) of HALEU at recent market prices.
  • HALEU will be required to enable many nuclear reactors, such as SMRs (small modular reactors), to operate in the future.
  • The Nuclear Energy Institute estimates that there may be a HALEU supply demand of approximately 3,000 metric tons by 2035(2).

ZAP Surgical Deals Two More Blows to Elekta in IP Suit, Removing Barriers to Mass Adoption of the ZAP-X Radiosurgery Platform

Retrieved on: 
Thursday, September 28, 2023
Legal, Technology, Surgery, Medical Devices, Health Technology, Professional Services, Biotechnology, Health, Robotics, Patent, Radiation, Failure, United States Patent and Trademark Office, Federal Patent Court (Germany), Federal court, Stanford University, Medicine, Judgement, Appeal, IAEA, Patient, ZAP, Isotope, 3D printing, Elekta, Neurosurgery

In April 2019, Elekta alleged that the ZAP-X infringed upon its patent 7,296,648, which described a theoretical design for a radiosurgery device that was never brought to market.

Key Points: 
  • In April 2019, Elekta alleged that the ZAP-X infringed upon its patent 7,296,648, which described a theoretical design for a radiosurgery device that was never brought to market.
  • Elekta’s lawsuit against ZAP Surgical sought monetary damages with a three-fold enhancement for willful infringement, as well as an injunction prohibiting the importation, manufacture, use and sales of the ZAP-X.
  • The judicial panel meticulously reviewed Elekta's arguments and found them “unpersuasive”, thus settling the matter conclusively in favor of ZAP Surgical.
  • This German decision echoes the sentiments expressed by the U.S. courts, further strengthening ZAP Surgical's position in this protracted legal battle.